Advanced Colorectal Cancer
Tubular Adenocarcinoma of Sigmoid Colon
Male, 63 years
Patient Internal ID: 733100624
ICD-10 code
C18.7 Malignant Neoplasm of Sigmoid Colon
Diagnosis (Incl. Metastases/Stage) and Year
February 2021
Tubular Adenocarcinoma of Sigmoid Colon with Low-Grade Epithelial Dysplasia, Stage 4, (two derivatives) with Unverified Nodules in the Liver.
Previous Treatment
No previous treatment was given. From November 2021, the patient has been receiving Immunotherapy of UCB CIK + IL-2 every 3 weeks.
Prognosis and Survival Expectation
The prognosis remains poor, Advanced Colorectal Cancer median survival is around 30 months. The relative 5-year survival rate of Advanced Colorectal Cancer is 13%.
Treatment Provided
Autologous DCV (9 doses) and CIK (24 doses) with IL-2 over a period of 15 months. Additionally, the patient received Xenogeneic Preventive and Therapeutic Anti-Cancer Vaccine (PTAC) (10 vaccines), Mistletoe Therapy.
Patient Survival/Condition and Year
Date of Review: 20/01/2024
The patient has survived for 35 months since the diagnosis. He attends regular surveillance. In the latest PET/CT scan, no visible changes were reported in the Colon, however, the unverified nodules in the Liver were reported to be increased in volume. The patient has exceeded median survival of mCRC by 5 months. It can therefore be concluded that Immunotherapy has benefited in disease stabilization so far.
